Roundup St. Louis Trial Postponed, Increasing Speculation About Monsanto Settlement Negotiations

Days before the first of several thousand Roundup lawsuits pending in Missouri state court was set to go before a jury in St. Louis, the judge presiding over the claim has indicated that the trial date has been pushed back to January 2020, further increasing speculation that plaintiffs and Monsanto may be making progress toward settling the litigation.

Bayer and its Monsanto subsidiary currently face more than 18,400 product liability lawsuits brought by individuals who allege they developed non-Hodgkins lymphoma from Roundup exposure, with most of the claims pending in St. Louis, where the manufacturer’s headquarters are located.

Following a series of massive losses in the first three Roundup trials to go before juries in California state court and at the federal level, each of which resulted in verdicts requiring the manufacturer to pay tens of million in damages to plaintiffs, all eyes have been on a Roundup St. Louis trial that was expected to begin August 19.

Learn More About

Roundup Lawsuits

Exposure to RoundUp May Increase Risk of Non-Hodgkins Lymphoma and Other Cancers. Lawsuits Reviewed Nationwide.

Learn More About this Lawsuit See If You Qualify For Compensation

The case involves claims filed by Sharlean Gordon, and was being closely watched as a “bellwether” to gauge how St. Louis juries may respond to certain evidence testimony that is likely to be raised in thousands of other lawsuits pending in Missouri state court against Monsanto, which is a major local employer.

Bayer made the controversial decision to acquire Monsanto last year, taking on all liability the company faced as a result of failure to warn about the cancer risks associated with Roundup.

Following final judgments ranging between $25 million and $87 million in the first three cases to trial, Bayer has faced increasing pressure from shareholders to negotiate Roundup settlements that resolve the litigation, avoid years of litigation and eliminate the uncertainty of jury trials.

In the upcoming St. Louis case, Bayer was expected to test a new defense strategy involving the use of new expert witnesses from universities in Missouri, which was designed to capitalize on Monsanto’s positive reputation in the region. However, if the company is hit with another large damage award in St. Louis, it may greatly impact the amount that would need to be paid to settle the litigation.

On Monday, St. Louis County Court Judge Brian May indicated the Gordon trial has been rescheduled for January 2020, which likely occurred with the consent of all parties, since it was so close to the date of jury selections. According to a report by the non-profit investigative research group U.S. Right to Know, the mysterious delay further increases speculation that a Roundup settlement may be close.

Just days earlier, the U.S. District Judge presiding over hundreds of claims pending in the federal court system agreed to postpone deadlines in a Roundup bellwether process, delaying the start of the next federal trial and providing the parties additional time to prepare dozens of cases in the first two “waves” of claims that will be sent back to different U.S. Districts nationwide for individual trial dates next year.

Bayer is currently participating in a court ordered mediation process, involving the prominent mediator Ken Feinberg, who has guided some of the largest settlements in high-profile litigation in recent years, including funds to pay claims related to the BP oil spill, Volkswagen emissions scandal, General Motors ignition switch recall, September 11th Victim Compensation fund and others.

Several experts indicate that Bayer will need to pay billions to compensate individuals diagnosed with non-Hodgkins lymphoma following exposure to Roundup, and the cumulative liability from thousands of individual jury trials may be substantially higher, since juries have consistently hit the company with large punitive damage awards after finding that Monsanto acted with reckless disregard for the health and safety of consumers for years.


Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Leadership Development Committee for Suboxone Dental Injury Lawyers Established in Federal MDL
Leadership Development Committee for Suboxone Dental Injury Lawyers Established in Federal MDL (Posted yesterday)

The U.S. District Judge presiding over all Suboxone lawsuits has created a mentorship program to use the litigation to provide some attorneys an opportunity to gain experience in handling complex federal multidistrict litigations.

Gilead Settlement Resolves 2,625 HIV Drug Lawsuits Pending in Federal Courts for $40M
Gilead Settlement Resolves 2,625 HIV Drug Lawsuits Pending in Federal Courts for $40M (Posted 3 days ago)

Gilead says it will pay $40 million to resolve HIV drug lawsuits over Truvada, Atripla, Viread, Stribild and Complera pending in the federal court system, involving claims that the the company sat on safer formulations of the drugs for years to increase profits.